All news item

Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official

Nearly a third of New York health care workers so far eligible for the COVID-19 vaccine are taking a wait-and-see approach, eschewing the shots at least for the time being, city and state officials said Tuesday. Click here to read more.

By |2021-01-10T13:28:50+00:00January 10th, 2021|News-Articles|Comments Off on Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official

Study suggests Pfizer vaccine works against virus variant

New research suggests Pfizer’s COVID-19 vaccine can protect against a mutation found in the two more-contagious variants of the coronavirus that have erupted in Britain and South Africa. Click here to read more

By |2021-01-10T13:19:53+00:00January 10th, 2021|News-Articles|Comments Off on Study suggests Pfizer vaccine works against virus variant

Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says

The CEO of the world's biggest vaccine producer, Serum Institute, warns that there will not be enough COVID-19 vaccines for the global population until 2024. Medical ethicist Art Caplan spoke with Boston Public Radio on Wednesday about why richer countries are getting the COVID-19 vaccine first. "It's because the rich countries bought up the vaccine supply in advance, [...]

By |2020-12-18T13:39:02+00:00December 18th, 2020|News-Articles|Comments Off on Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says

First shipments of Pfizer vaccine to be delivered December 15

The first shipments of Pfizer's coronavirus vaccine will be delivered on December 15, according to an Operation Warp Speed document obtained by CNN on Tuesday. The document, provided to governors ahead of a call with the Vice President Monday, also estimated the first shipment of Moderna's vaccine will be delivered on December 22. Click here [...]

By |2020-12-03T16:15:19+00:00December 3rd, 2020|News-Articles|Comments Off on First shipments of Pfizer vaccine to be delivered December 15

Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

When President Donald Trump confirmed Oct. 2 that he was diagnosed with Covid-19, he received a cocktail of therapies — some of which hadn’t yet been approved for general use. Click here to read the full article

By |2020-11-12T23:47:17+00:00November 12th, 2020|News-Articles|Comments Off on Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

Make pre-approval Covid-19 vaccines available through expanded access, not an EUA

BioNTech, based in Mainz, Germany, announced positive results Monday about the Covid-19 vaccine it is developing with Pfizer. Click here to read more.

By |2020-11-11T22:11:52+00:00November 11th, 2020|News-Articles|Comments Off on Make pre-approval Covid-19 vaccines available through expanded access, not an EUA

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. [...]

By |2020-10-30T16:52:07+00:00October 30th, 2020|News-Articles|Comments Off on The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

Learning From the Past? Globalization and Coronavirus Spread

Ana Lita, PhD GBI Co-Founder and Executive Director As we are currently facing the COVID - 19 pandemic, it is evident that we all need more factual information about how to prepare and possibly manage a disaster of this magnitude. At the Global Bioethics Initiative, we want to help address the information gaps and support others to be prepared for the peak of the Coronavirus infection. We are pleased to announce that we will be organizing a [...]

By |2020-04-09T23:41:35+00:00March 29th, 2020|News-Articles|Comments Off on Learning From the Past? Globalization and Coronavirus Spread

Testimonials: GBI & MORU Summer School – Bangkok | August 5 – 9, 2019

I am thankful to have had the chance to attend the summer school in Bangkok organized by the Global Bioethics Initiative (GBI), in collaboration with the Department of Bioethics & Engagement, Mahidol Oxford Tropical Medicine Research Unit (MORU), University of Oxford. I was also the beneficiary of a partial scholarship. In my opinion, one of the [...]

By |2020-04-09T23:41:49+00:00September 20th, 2019|News-Articles|Comments Off on Testimonials: GBI & MORU Summer School – Bangkok | August 5 – 9, 2019

2020 GBI Summer School to go Online as a Virtual Event

Due to the COVID-19 pandemic, in order to provide a level of certainty in planning for our Summer School in 2020, we have decided to deliver this program online as a virtual event. Dates will be announced shortly. We will use Zoom technology, for more information click here. We are working with our instructors to [...]

By |2020-03-26T20:37:34+00:00March 22nd, 2020|News-Articles|Comments Off on 2020 GBI Summer School to go Online as a Virtual Event